The global Research Antibodies Marketwas valued at USD 6.71 billion in 2016 and is projected to reach USD 14.12billion by 2025, growing at a CAGR of 11.3% from 2017 to 2025.
Biotechnology is a huge sector with investment from govt. and private players funding. The research and development department is increasing the number of healthcare projects and antibody based medicinal researches. This makes the antibody market rise in the market value.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Research Activity and funds in R&D
1.2 GrowingIndustrial and academic projects and collaborations
1.3 Growing Demand Of Personalized Medicine
2. Market Restraints
2.1 Quality issues regarding Antibodies
2.2 Increased Competition
Market Segmentation:
1. Global Research Antibodies Market, by Technology:
1.1 Western Blotting
1.2 Flow Cytometry
1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
1.4 Immunohistochemistry
1.5 Immunofluorescence
1.6 Immunoprecipitation
1.7 Other Technologies
2. Global Research Antibodies Market, by End User:
2.1 Pharmaceutical and Biotechnology Companies
2.2 Academic and Research Institutes
2.3 Contract Research Organizations
3. Global Research Antibodies Market, by Product:
3.1 Reagents
3.1.1 Media & Sera
3.1.2 Stains & Dyes
3.1.3 Fixatives
3.1.4 Buffers
3.1.5 Solvents
3.1.6 Enzymes
3.1.7 Probes
3.1.8 Other Reagents
3.2 Antibodies
3.2.1 By Type
3.2.1.1 Primary Antibodies
3.2.1.2 Secondary Antibodies
3.2.2 By Source
3.2.2.1 Mice
3.2.2.2 Rabbits
3.2.2.3 Other Sources
3.2.3 By Research Area
3.2.3.1 Oncology
3.2.3.2 Infectious Diseases
3.2.3.3 Immunology
3.2.3.4 Neurobiology
3.2.3.5 Stem Cells
3.2.3.6 Other Research Areas
4. Global Research Antibodies Market, By Application:
4.1 Proteomics
4.2 Drug Development
4.3 Genomics
5. Global Research Antibodies Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific Inc.
2. Merck Group
3. Abcam PLC
4. Becton, Dickinson and Company
5. Cell Signaling Technology, Inc.
6. Bio-Rad Laboratories, Inc.
7. F. Hoffmann-La Roche Ltd
8. Agilent Technologies, Inc.
9. Danaher Corporation
10. Lonza
11. Genscript
12. Perkinelmer, Inc.
13. Biolegend, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Research Antibodies Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL RESEARCH ANTIBODIES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL RESEARCH ANTIBODIES MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL RESEARCH ANTIBODIES MARKET, BY TECHNOLOGY:
5.1 Western Blotting
5.2 Flow Cytometry
5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
5.4 Immunohistochemistry
5.5 Immunofluorescence
5.6 Immunoprecipitation
5.7 Other Technologies
6 GLOBAL RESEARCH ANTIBODIES MARKET, BY END USER:
6.1 Pharmaceutical and Biotechnology Companies
6.2 Academic and Research Institutes
6.3 Contract Research Organizations
7 GLOBAL RESEARCH ANTIBODIES MARKET, BY PRODUCT:
7.1 Reagents
7.1.1 Media & Sera
7.1.2 Stains & Dyes
7.1.3 Fixatives
7.1.4 Buffers
7.1.5 Solvents
7.1.6 Enzymes
7.1.7 Probes
7.1.8 Other Reagents
7.2 Antibodies
7.2.1 By Type
7.2.1.1 Primary Antibodies
7.2.1.2 Secondary Antibodies
7.2.2 By Source
7.2.2.1 Mice
7.2.2.2 Rabbits
7.2.2.3 Other Sources
7.2.3 By Research Area
7.2.3.1 Oncology
7.2.3.2 Infectious Diseases
7.2.3.3 Immunology
7.2.3.4 Neurobiology
7.2.3.5 Stem Cells
7.2.3.6 Other Research Areas
8 GLOBAL RESEARCH ANTIBODIES MARKET, BY APPLICATION:
8.1 Proteomics
8.2 Drug Development
8.3 Genomics
9 GLOBAL RESEARCH ANTIBODIES MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL RESEARCH ANTIBODIES MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Merck Group
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Abcam PLC
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Becton, Dickinson and Company
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Cell Signaling Technology, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Agilent Technologies, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Danaher Corporation
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Lonza
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Genscript
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Perkinelmer, Inc.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
11.13 Biolegend, Inc.
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments
12 Appendix
12.1 Related Reports
The Antibodies for Research Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...
The Stem Cell Research Antibodies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Executive Summary
Azoth Analytics has released a research report titled "Global Thyroid Eye Disease Treatment Market (2023 Edition)" which provides a complete analysis of the global Thyroid Eye Disease Treatment industry in terms of market segmentation by Therapeutic Type (Monoclonal An...
The global Secondary Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Double Specificity Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...
The global Diagnostic Specialty Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market play...
The global Single Bivalent Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Vascular Endothelial Growth Factor (VEGF) Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which ...
The global Fc Protein and Glycoengineered Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help m...
The global HER2 Antibodies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...